Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Endocannabinoid System
100%
Schizophrenia Treatment
100%
System Potential
100%
Cannabinoid Receptor 1 (CB1R)
33%
Molecular Mechanism
22%
Schizophrenia
22%
Brain Development
22%
Epidemiological Evidence
22%
Cannabis Use
11%
Central Nervous System
11%
Molecular Pathways
11%
Genetic Heterogeneity
11%
Genetic Risk
11%
Potential Ecological Risk
11%
Clinical Evidence
11%
Psychosis
11%
Brain Function
11%
Pharmacological Approaches
11%
Animal Behavior
11%
Human Behavior
11%
Novel Therapeutic Targets
11%
Multiple Varieties
11%
Pathological Evidence
11%
Cellular Process
11%
Therapeutic Interventions
11%
Synaptic Communication
11%
Etiology of Schizophrenia
11%
Multiple Environmental Factors
11%
Genetically Engineered Animals
11%
Neuroscience
Endocannabinoid System
100%
Treatment of Schizophrenia
100%
Endocannabinoid
50%
Schizophrenia
50%
Brain Development
33%
Genetics
33%
Central Nervous System
16%
Behavior (Neuroscience)
16%
Cannabis
16%
Cannabinoid Receptor
16%
Cannabinoid Receptor Type 1
16%
Risk Factor
16%
Psychosis
16%
Cellular Processes
16%
Pharmacology, Toxicology and Pharmaceutical Science
Endocannabinoid System
100%
Schizophrenia
100%
Endocannabinoid
50%
Cannabinoid Receptor
33%
Clinical Study
16%
Pathophysiology
16%
Preclinical Study
16%
Cannabis
16%
Cellular Processes
16%
Genetic Risk
16%
Transgenic Animal
16%
Psychosis
16%